Trichotillomania: An Overview - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

Trichotillomania: An Overview

Description:

Trichotillomania: An Overview David Dia, PhD, LCSW, CCBT University of Tennessee Disclosures No financial disclosures or conflicts of interest to report Information ... – PowerPoint PPT presentation

Number of Views:577
Avg rating:3.0/5.0
Slides: 38
Provided by: David3158
Category:

less

Transcript and Presenter's Notes

Title: Trichotillomania: An Overview


1
Trichotillomania An Overview
  • David Dia, PhD, LCSW, CCBT
  • University of Tennessee

2
Disclosures
  • No financial disclosures or conflicts of interest
    to report
  • Information is presented as educational. It is
    not intended to diagnosis, treat, or be a
    substitute for expert medical or mental health
    care.

3
Overview
  • General information
  • Medication
  • Psychosocial Treatments

4
What is in a name?
  • Trich hair
  • Tillo pulling
  • Mania impulse

5
Diagnosis DSM IV-TR
  • Impulse Control Disorder
  • May be related to Obsessive compulsive disorder
    (anxiety) or tic disorder
  • Pathological Gambling

6
Diagnosis DSM IV-TR
  • Criteria
  • Recurrent pulling out of ones hair with
    noticeable hair loss
  • Sense of tension before pulling or when
    attempting to resist
  • Pleasure, gratification, or relief when pulling
    out hair
  • Causes clinically significant impairment

7
Other terms to know
  • Trichophagia eating the hairs
  • Bezoars hair balls
  • Alopecia hair loss

8
General Facts
  • Estimated 2.5 million people (.6 lifetime)
  • Average age of onset 13 years old
  • 3.4 Females vs. 1.5 of Males hair loss
  • Tends to have a waxing and waning course

9
General Facts
  • Can be triggered and exacerbated by anxiety
  • Two types, not mutually exclusive
  • Focused vs. automatic

10
General Facts
  • Only 15 of adults experience significant
    improvement with community treatment!
  • Most (55) believed their clinician
  • Did not have significant knowledge of the
    disorder
  • Did not have knowledge of evidenced based
    treatment

11
Comorbidity
  • Adult Sample
  • Mood
  • Anxiety
  • Substance abuse
  • Personality D/O
  • Pediatric Sample
  • Anxiety
  • Depression
  • Disruptive Behavioral
  • Tics

12
Consequences
  • Lower life satisfaction
  • Higher levels of stress
  • Lower self-esteem

13
Suspected Causes
  • Genetic Component
  • 5HT2A, hoxB8, and SLITRT1
  • Neurotransmitters
  • Dopamine
  • Monoamine system (MAOI)
  • Gultamate (precursor to GABA)
  • Neuroadrenaline system
  • Serotonin?

14
Suspected Causes
  • Inferior frontal cortex cognition
  • Amygdala-hippocampal formation affect
    regulation
  • Putamen habit learning
  • VTA and Nucleus accumbens
  • Mediates reward process

15
Compulsive Skin Picking
  • General Information
  • 2 to 4 of the population
  • More common in females
  • Bimodal onset --
  • Late childhood to early adolescents
  • 30 to 45 years old
  • Causes
  • Genetic (hoxb8)

16
Overview of Treatment
  • No randomized control studies with pediatric
  • Behavioral treatments with adults demonstrate
    efficacy
  • Uncontrolled studies with pediatric show similar
    results as adults
  • SSRIs (double blind, placebo controlled) have no
    efficacy

17
Overview of Treatment
  • Supportive or psychodynamic therapy no or minimal
    affect

18
Treatment -- Medications
  • Mancini et al. (2009) -- pediatric
  • Retrospective chart review (N 11)
  • 10 tried on SRI and 1 on antipsychotic
  • 2 on SRI and 9 on antipsychotic
  • 2 remitted
  • Results favored antipsychotics
  • Risperidone (Risperdol)
  • Quetiapine (Seroquel)

19
Medications - Adults
  • SSRI vs. control condition
  • 3 studies
  • Tricyclic vs. control
  • Clomipramine (Anafranil) 2 studies
  • HRT vs. SSRI
  • HRT vs. Clomipramine
  • Clomipramine vs. SSRI
  • (SSRIs fluvoxamine, fluoxetine, , sertraline,
    citalopram)

20
Medications Experimental -- Adults
  • Opioid antagonist Naltrexone and Nalmefene
  • Mood Stabilizers lithium and Valproic acid
    (Depakote)
  • Dopamine reuptakers inhibitors Focalin,
    Ritalin, Wellburtrin)
  • Norepinephrine inhibitor clomipramine
  • Glutamatergic N-acetylcysteine

21
Medical
  • Neurosurgery, Transcranial Magnetic Stimulation
    (TMS), ECT
  • No evidence

22
Psychosocial Treatments
  • HRT/CBT vs. control
  • 5 studies pediatric
  • 77 to 61 clinically significant changes
  • For example, 16 to 5 of the MBHHPS
  • 5 controlled studies with adults
  • 91 to 61 reduction
  • Hypnotherapy
  • Two uncontrolled, small studies with adults

23
Treatment Guidelines Pediatric
  • Psychoeducation
  • 0 to 7 years
  • Response prevention implemented with parents
  • Older than 7 years
  • Habit reversal therapy

24
Treatment Guidelines Pediatric
  • If there continues to be significant impairment
    from trich despite prolonged behavioral treatment
    with experienced clinician consider
  • N-acetylcysteine
  • Initial dose 600mg, titrated to a max does of
    1200mg BID
  • Clomipramine
  • (Medications, including OTR, needs to be
    dispensed/recommended by physician)

25
Treatment - CSP
  • One Double Blind Study
  • Fluoxetine improvement in 2 or 3 outcome
    measures
  • Open label
  • Fluvoxamine, Fluoxetine, Lamotrigine,
    Escitalopram, N-acetylcysteine

26
Treatment - CSP
  • 3 Psychosocial studies
  • HRT with 3 month F/U
  • HRT ACT
  • Internet based treatment 62 responders
  • 115 participants
  • 15 completed all three phases

27
Comprehensive ModelMansueto et al. (1999)
  • Phase I
  • Assessment and functional analysis
  • Phase 2
  • Identify and target modalities
  • Phase 3
  • Identify and implement strategies
  • Phase 4
  • Evaluation and modification

28
Phase I
  • Two types of antecedents to pulling
  • Cues that trigger the urge to pull
  • Discriminative stimuli that facilitates pulling
  • Actually pulling
  • Consequences of pulling
  • Maintains pulling
  • Terminate pulling

29
Phase I
  • Cues
  • External settings and implements associated
  • Internal affective states, visual or tactile
    sensations, cognitive cues
  • Discrimitive stimuli (set the stage)
  • External environment free of potential
    observers, presences of pull instruments
  • Internal urge, posture cues, cognitive

30
Phase I
  • Preparation
  • Specific Hair selected
  • Disposition of hair
  • Discarded
  • Retrain
  • Inspect
  • Bite/swallow
  • Wrapping hair / tickle

31
Intervention Phase I
  • Self-monitoring

32
Phase 2
  • Cognitive modality
  • Cognitive restructuring, guided self dialogue
  • Affective modality
  • Relaxation exercises, exposure, positive imagery,
    stress management
  • Motoric modality
  • Finger tip bandages, gloves, bracelets, eye
    glasses, scarf's, etc.
  • Silly putty, worry beads, soft brush

33
Phase 2
  • Sensory modality
  • Numbing cream, brushing hair, washing hair
    vigorously, shampoo
  • Gummy bears, sunflower seeds, dental floss, koosh
    balls, frayed blankets
  • Dying hair, cutting finger nails
  • Environmental
  • Removing tweezers, covering mirrors
  • Behavioral plans, stimulus control

34
Phase 2
  • Habit reversal
  • Self-monitoring
  • Awareness training
  • Hair pulling and high risk situations
  • Stimulus control
  • Decrease opportunities or interfere
  • Competing response intervention

35
Phase 3
  • Identify and choose treatment strategies
  • Client to use strategy for at least one week
  • Primary issue getting the client to use
    strategy consistently

36
Phase 4
  • Evaluation and Modification

37
Questions
Write a Comment
User Comments (0)
About PowerShow.com